China’s Wuxi Pharma looks for $150m dose in senior
New York-listed Chinese medical technology provider Wuxi Pharmatech is cooking up a $150m dual tranche loan with one mandated lead arranger and bookrunner.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: